| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |